24 results on '"Gurley, M."'
Search Results
2. EP06.03-11 Characterization of KRAS Mutations in Black Patients with NSCLC at an Urban Academic Medical Center
- Author
-
Dressler, D., primary, Fuchs, J.R., additional, Menon, S.V., additional, Hewlett, M.P., additional, Katam, N., additional, Gurley, M., additional, Chae, Y.K., additional, Boumber, Y., additional, Mohindra, N., additional, Vakkalagadda, C.V., additional, and Patel, J.D., additional
- Published
- 2023
- Full Text
- View/download PDF
3. Outpatient management of pneumothorax after fine-needle aspiration: economic advantages for the hospital and patient.
- Author
-
Gurley, M B, primary, Richli, W R, additional, and Waugh, K A, additional
- Published
- 1998
- Full Text
- View/download PDF
4. Microbial Etiology and Clinical Characteristics of Distributive Shock
- Author
-
Bamberger, D. M., primary and Gurley, M. B., additional
- Published
- 1994
- Full Text
- View/download PDF
5. Criticality Studies of Graphite Moderated Production Reactors
- Author
-
SOUTHERN SCIENCE APPLICATIONS INC DUNEDIN FL, Cole, R. M., Gurley, M. K., Keller, Jr., R. D., Kirby, K. D., Turner, S. E., Mditchell, III, W., SOUTHERN SCIENCE APPLICATIONS INC DUNEDIN FL, Cole, R. M., Gurley, M. K., Keller, Jr., R. D., Kirby, K. D., Turner, S. E., and Mditchell, III, W.
- Abstract
The objective of the study was to examine the feasibility of using commercially available graphite in small production reactors. Three different- size reactors, each with a different coolant, were investigated, and an assessment was made of the effect of parasitic neutron-absorbing material in the graphite, either as naturally-occurring impurities or as intentionally-added spikants. In addition, a brief survey of methods of manufacturing and of purifying graphite was performed.
- Published
- 1980
6. Survey of the Current Status of the LWR and Projected Improvements.
- Author
-
SOUTHERN SCIENCE APPLICATIONS INC DUNEDIN FL, Turner,S E, Kirby,K D, Hancock,R P, Gurley,M K, Elgin,W J, SOUTHERN SCIENCE APPLICATIONS INC DUNEDIN FL, Turner,S E, Kirby,K D, Hancock,R P, Gurley,M K, and Elgin,W J
- Abstract
This study is prepared to provide a basis for projecting and substantiating near and immediate-term improvements in the Light Water Reactor (LWR) resource utilization. The evaluation is described in three parts: (1) History of LWR (2) Fuel Utilization: A brief history of LWR fuel burnup experience, with interpretation/extrapolation to the year 2000. (3) Potential Improvements: Survey of potential savings in uranium resources from increased fuel burnup to an achievable target value, and an assessment of state-of-the-art capability of reaching that objective. In addition, identification of other potential design/fuel management improvements and attendant potential gains and uncertainties. (4) Alternate Nuclear Technologies: Estimation of savings in uranium resources by ultilizing the U/Th cycle and Pu/U recycle, and an assessment of risk elements, probable costs, and industry willingness to support implementation on a commercial scale. It is concluded that an achievable saving of about 8% is possible in the PWR cycle solely by extending fuel burnup (perhaps slightly larger in BWRs) and another 8% by decreased reload batch size. This is a naturally occurring evolution which government funding may only accelerate. A further improvement by altering the fuel cycle (fast shuffle and/or increased number of core zones) may be realized (at higher risk) by more extensive and expensive design modifications. Alternate fuel cycles could substantially increase the savings, but at considerable expense and yet higher risk. (Author)
- Published
- 1978
7. The influence of infantile handling, age and strain on alcohol selection in mice
- Author
-
Jones, B.C., primary, Goldstine, R.N., additional, Kegel, M., additional, Gurley, M., additional, and Reyes, Edward, additional
- Published
- 1985
- Full Text
- View/download PDF
8. The human lymph node germinal center cell: characterization and isolation by using two-color flow cytometry.
- Author
-
Weinberg, D S, primary, Ault, K A, additional, Gurley, M, additional, and Pinkus, G S, additional
- Published
- 1986
- Full Text
- View/download PDF
9. Experimental Street Virus Rabies in White Mice. Studies on Passive Immunization. II.
- Author
-
Hoyt, A., primary and Gurley, M. K., additional
- Published
- 1938
- Full Text
- View/download PDF
10. Experimental Street-Virus Rabies in White Mice. Studies on Passive Immunization. I.
- Author
-
Hoyt, A., primary and Gurley, M. K., additional
- Published
- 1937
- Full Text
- View/download PDF
11. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
- Author
-
Dimitrios Farmakiotis, Susie Owenby, Arturo Loaiza-Bonilla, Mansi R. Shah, Matthew Puc, Vadim S. Koshkin, Ahmad Daher, Prakash Peddi, Cameron Rink, Heloisa P. Soares, Eneida R. Nemecek, Mehmet Asim Bilen, Sanjay Mishra, Lidia Schapira, Amit Verma, Ali Raza Khaki, Chih-Yuan Hsu, Sandy DiLullo, Mark Bonnen, Jeanna Knoble, Carla Casulo, Umit Topaloglu, Jorge A. Garcia, Geoffrey Shouse, Praveen Vikas, Clarke A. Low, Archana Ajmera, George D. Demetri, Leyre Zubiri, Grace Glace, Shannon K. McWeeney, Susan Yackzan, Pamela C Egan, Rachel P. Rosovsky, Salvatore Del Prete, Anthony P. Gulati, Lane R. Rosen, Andy Futreal, Merry Jennifer Markham, Sabitha Prabhakaran, Alicia K. Morgans, Sarah Nagle, Lisa Weissmann, Albert C. Yeh, Ziad Bakouny, Stephanie Berg, David Gill, Marcus Messmer, Ryan Nguyen, Terence Duane Rhodes, Vikram M. Narayan, Matthew D. Galsky, Arielle Elkrief, Lori J. Rosenstein, Roy S. Herbst, Justin Shaya, Thorvardur R. Halfdanarson, Douglas B. Johnson, Orestis A. Panagiotou, Sanjay G. Revankar, Toni K. Choueiri, Yu Shyr, Fiona Busser, Kaitlin M. Kelleher, Nicole M. Kuderer, Paul L. Weinstein, Anup Kasi, Grace Shaw, Adam J. Olszewski, Catherine Curran, Samuel M. Rubinstein, Angelo Cabal, Michael H. Bar, John F. Deeken, Vivek Subbiah, Abdul Hai Mansoor, Hina Khan, Rana R. McKay, Catherine Stratton, Saurabh Dahiya, Marc A. Rovito, John Philip, Sanjay Shete, Oscar K. Serrano, Julie Fu, Daniel W. Bowles, Candice Schwartz, Tian Zhang, Pier Vitale Nuzzo, Eric H. Bernicker, Wenxin Xu, Genevieve M. Boland, Sarah Wall, Babar Bashir, Solange Peters, Neeta K. Venepalli, Sandeep H. Mashru, William A. Wood, Anne H. Angevine, Mary F. Mulcahy, Gilberto Lopes, Justin F. Gainor, Jessica Hawley, Monika Joshi, Christopher R. Friese, Navid Hafez, Heather H. Nelson, Gregory J. Riely, Jordan Kharofa, Nilo Azad, Chintan Shah, Gerald Batist, Mary Salazar, Rosemary Zacks, Alice Zhou, Lawrence E. Feldman, Paul Fu, Gary H. Lyman, Nathaniel Bouganim, John A. Steinharter, Shilpa Gupta, Matthias Weiss, Peter Paul Yu, Susan Van Loon, Jamie Stratton, Karen Vega-Luna, Tyler Masters, Christopher Lemmon, Aakash Desai, Bryan A. Faller, Jessica M. Clement, Zhuoer Xie, Keith Stockerl-Goldstein, Corrie A. Painter, Gabrielle Bouchard, Rulla M. Tamimi, Daruka Mahadevan, Rimma Belenkaya, Jill S. Barnholtz-Sloan, Jarushka Naidoo, Amelie G. Ramirez, Philip E. Lammers, Elizabeth A. Griffiths, Michael J. Gurley, X. Li, Jonathan Riess, Syed A. Ahmad, Daniel Blake Flora, Salma K. Jabbour, Jared D. Acoba, Neeraj Agarwal, Ang Li, Sarah Mushtaq, Firas Wehbe, Tanios Bekaii-Saab, Donald C. Vinh, Emily Hsu, Ryan Monahan, Petros Grivas, Harry Menon, John M. Nakayama, Janice M. Mehnert, Elizabeth Marie Wulff-Burchfield, Sara Matar, Paul E. Oberstein, Mary M. Pasquinelli, Axel Grothey, Jack West, John C. Leighton, Dawn L. Hershman, Leslie A. Fecher, Aditya Bardia, Sumit A. Shah, Barbara Logan, Kerry L. Reynolds, Michael A. Thompson, Robert L. Rice, Erin Cook, Trisha Wise-Draper, Christine Bestvina, Daniel Castellano, Paolo Caimi, K. M.Steve Lo, Ruben A. Mesa, Maheen Z. Abidi, Alvaro G. Menendez, Daniel G. Stover, Colleen Lewis, Bertrand Routy, Deborah B. Doroshow, Carmen C. Solorzano, M. Wasif Saif, Rohit Bishnoi, Michael Glover, David D. Chism, Briana Barrow, Christopher McNair, Dimpy P. Shah, Erin A. Gillaspie, Andrea J. Zimmer, Andrew Schmidt, Jessica K. Altman, Michelle Marcum, Rawad Elias, Balazs Halmos, Karen Stauffer, Gayathri Nagaraj, Ardaman Shergill, Mark E. Dailey, Catherine Handy Marshall, Pramod K. Srivastava, Shuchi Gulati, Alokkumar Jha, Mateo Bover Larroya, Mark A. Lewis, Young Soo Rho, James L. Chen, Eli Van Allen, Julie Tsu Yu Wu, Antonio Giordano, Amit Kulkarni, Joerg Rathmann, Donna R. Rivera, Narjust Duma, Maryam B. Lustberg, Theresa M. Carducci, Jeremy L. Warner, Elizabeth Robilotti, Patricia LoRusso, Rohit Jain, Amit Sanyal, Nizar M. Tannir, Kent Hoskins, Nathan A. Pennell, Brian I. Rini, Suki Subbiah, COVID-19 and Cancer Consortium, Abidi, M., Acoba, J.D., Agarwal, N., Ahmad, S., Ajmera, A., Altman, J., Angevine, A.H., Azad, N., Bar, M.H., Bardia, A., Barnholtz-Sloan, J., Barrow, B., Bashir, B., Belenkaya, R., Berg, S., Bernicker, E.H., Bestvina, C., Bishnoi, R., Boland, G., Bonnen, M., Bouchard, G., Bowles, D.W., Busser, F., Cabal, A., Caimi, P., Carducci, T., Casulo, C., Chen, J.L., Clement, J.M., Chism, D., Cook, E., Curran, C., Daher, A., Dailey, M., Dahiya, S., Deeken, J., Demetri, G.D., DiLullo, S., Duma, N., Elias, R., Faller, B., Fecher, L.A., Feldman, L.E., Friese, C.R., Fu, P., Fu, J., Futreal, A., Gainor, J., Garcia, J., Gill, D.M., Gillaspie, E.A., Giordano, A., Glace, M.G., Grothey, A., Gulati, S., Gurley, M., Halmos, B., Herbst, R., Hershman, D., Hoskins, K., Jain, R.K., Jabbour, S., Jha, A., Johnson, D.B., Joshi, M., Kelleher, K., Kharofa, J., Khan, H., Knoble, J., Koshkin, V.S., Kulkarni, A.A., Lammers, P.E., Leighton, J.C., Lewis, M.A., Li, X., Li, A., Lo, KMS, Loaiza-Bonilla, A., LoRusso, P., Low, C.A., Lustberg, M.B., Mahadevan, D., Mansoor, A.H., Marcum, M., Markham, M.J., Handy Marshall, C., Mashru, S.H., Matar, S., McNair, C., McWeeney, S., Mehnert, J.M., Menendez, A., Menon, H., Messmer, M., Monahan, R., Mushtaq, S., Nagaraj, G., Nagle, S., Naidoo, J., Nakayama, J.M., Narayan, V., Nelson, H.H., Nemecek, E.R., Nguyen, R., Nuzzo, P.V., Oberstein, P.E., Olszewski, A.J., Owenby, S., Pasquinelli, M.M., Philip, J., Prabhakaran, S., Puc, M., Ramirez, A., Rathmann, J., Revankar, S.G., Rho, Y.S., Rhodes, T.D., Rice, R.L., Riely, G.J., Riess, J., Rink, C., Robilotti, E.V., Rosenstein, L., Routy, B., Rovito, M.A., Saif, M.W., Sanyal, A., Schapira, L., Schwartz, C., Serrano, O., Shah, M., Shah, C., Shaw, G., Shergill, A., Shouse, G., Soares, H.P., Solorzano, C.C., Srivastava, P.K., Stauffer, K., Stover, D.G., Stratton, J., Stratton, C., Subbiah, V., Tamimi, R., Tannir, N.M., Topaloglu, U., Van Allen, E., Van Loon, S., Vega-Luna, K., Venepalli, N., Verma, A.K., Vikas, P., Wall, S., Weinstein, P.L., Weiss, M., Wise-Draper, T., Wood, W.A., Xu, W.V., Yackzan, S., Zacks, R., Zhang, T., Zimmer, A.J., and West, J.
- Subjects
Prognostic variable ,medicine.medical_specialty ,business.industry ,Cancer ,General Medicine ,Odds ratio ,Aged ,Antiviral Agents/therapeutic use ,Azithromycin/therapeutic use ,Betacoronavirus ,Cause of Death ,Comorbidity ,Coronavirus Infections/drug therapy ,Coronavirus Infections/epidemiology ,Coronavirus Infections/mortality ,Databases, Factual ,Female ,Humans ,Hydroxychloroquine/therapeutic use ,Male ,Middle Aged ,Neoplasms/epidemiology ,Neoplasms/mortality ,Neoplasms/therapy ,Pandemics ,Pneumonia, Viral/drug therapy ,Pneumonia, Viral/epidemiology ,Pneumonia, Viral/mortality ,Prognosis ,Risk Factors ,030204 cardiovascular system & hematology ,medicine.disease ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Cohort ,Clinical endpoint ,Medicine ,030212 general & internal medicine ,business ,Cause of death ,Cohort study - Abstract
Summary Background Data on patients with COVID-19 who have cancer are lacking. Here we characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify potential prognostic factors for mortality and severe illness. Methods In this cohort study, we collected de-identified data on patients with active or previous malignancy, aged 18 years and older, with confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection from the USA, Canada, and Spain from the COVID-19 and Cancer Consortium (CCC19) database for whom baseline data were added between March 17 and April 16, 2020. We collected data on baseline clinical conditions, medications, cancer diagnosis and treatment, and COVID-19 disease course. The primary endpoint was all-cause mortality within 30 days of diagnosis of COVID-19. We assessed the association between the outcome and potential prognostic variables using logistic regression analyses, partially adjusted for age, sex, smoking status, and obesity. This study is registered with ClinicalTrials.gov, NCT04354701, and is ongoing. Findings Of 1035 records entered into the CCC19 database during the study period, 928 patients met inclusion criteria for our analysis. Median age was 66 years (IQR 57–76), 279 (30%) were aged 75 years or older, and 468 (50%) patients were male. The most prevalent malignancies were breast (191 [21%]) and prostate (152 [16%]). 366 (39%) patients were on active anticancer treatment, and 396 (43%) had active (measurable) cancer. At analysis (May 7, 2020), 121 (13%) patients had died. In logistic regression analysis, independent factors associated with increased 30-day mortality, after partial adjustment, were: increased age (per 10 years; partially adjusted odds ratio 1·84, 95% CI 1·53–2·21), male sex (1·63, 1·07–2·48), smoking status (former smoker vs never smoked: 1·60, 1·03–2·47), number of comorbidities (two vs none: 4·50, 1·33–15·28), Eastern Cooperative Oncology Group performance status of 2 or higher (status of 2 vs 0 or 1: 3·89, 2·11–7·18), active cancer (progressing vs remission: 5·20, 2·77–9·77), and receipt of azithromycin plus hydroxychloroquine (vs treatment with neither: 2·93, 1·79–4·79; confounding by indication cannot be excluded). Compared with residence in the US-Northeast, residence in Canada (0·24, 0·07–0·84) or the US-Midwest (0·50, 0·28–0·90) were associated with decreased 30-day all-cause mortality. Race and ethnicity, obesity status, cancer type, type of anticancer therapy, and recent surgery were not associated with mortality. Interpretation Among patients with cancer and COVID-19, 30-day all-cause mortality was high and associated with general risk factors and risk factors unique to patients with cancer. Longer follow-up is needed to better understand the effect of COVID-19 on outcomes in patients with cancer, including the ability to continue specific cancer treatments. Funding American Cancer Society, National Institutes of Health, and Hope Foundation for Cancer Research.
- Published
- 2020
- Full Text
- View/download PDF
12. Plutonium-238 production in commercial water reactors experimental and analytical program. Report for the period, July 1, 1973--September 30, 1974
- Author
-
Gurley, M
- Published
- 1974
- Full Text
- View/download PDF
13. Plutonium-238 production in commercial water reactors experimental and analytical program. Annual report for fiscal year 1973
- Author
-
Gurley, M
- Published
- 1973
- Full Text
- View/download PDF
14. Highland Park Shooting Anniversary: From Tragedy to Strategy.
- Author
-
Hollingsworth JM, Gurley M, Farley S, Cram JN, and Hendren BP
- Abstract
Competing Interests: Disclosure: The authors declare that they have nothing to disclose.
- Published
- 2024
- Full Text
- View/download PDF
15. Representing and utilizing clinical textual data for real world studies: An OHDSI approach.
- Author
-
Keloth VK, Banda JM, Gurley M, Heider PM, Kennedy G, Liu H, Liu F, Miller T, Natarajan K, V Patterson O, Peng Y, Raja K, Reeves RM, Rouhizadeh M, Shi J, Wang X, Wang Y, Wei WQ, Williams AE, Zhang R, Belenkaya R, Reich C, Blacketer C, Ryan P, Hripcsak G, Elhadad N, and Xu H
- Subjects
- Humans, Electronic Health Records, Natural Language Processing, Narration, Data Science, Medical Informatics
- Abstract
Clinical documentation in electronic health records contains crucial narratives and details about patients and their care. Natural language processing (NLP) can unlock the information conveyed in clinical notes and reports, and thus plays a critical role in real-world studies. The NLP Working Group at the Observational Health Data Sciences and Informatics (OHDSI) consortium was established to develop methods and tools to promote the use of textual data and NLP in real-world observational studies. In this paper, we describe a framework for representing and utilizing textual data in real-world evidence generation, including representations of information from clinical text in the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), the workflow and tools that were developed to extract, transform and load (ETL) data from clinical notes into tables in OMOP CDM, as well as current applications and specific use cases of the proposed OHDSI NLP solution at large consortia and individual institutions with English textual data. Challenges faced and lessons learned during the process are also discussed to provide valuable insights for researchers who are planning to implement NLP solutions in real-world studies., Competing Interests: Declaration of Competing Interest Dr. Hua Xu and The University of Texas Health Science Center at Houston have research related financial interests at Melax Technologies Inc. Dr. Xiaoyan Wang has related financial interests at Sema4 Mount Sinai Genomics Inc., (Copyright © 2023 Elsevier Inc. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF
16. The association of phosphodiesterase-5 inhibitors with the biochemical recurrence-free and overall survival of patients with prostate cancer following radical prostatectomy.
- Author
-
Danley KT, Tan A, Catalona WJ, Leikin R, Helenowski I, Jovanovic B, Gurley M, and Kuzel TM
- Subjects
- Aged, Humans, Male, Middle Aged, Phosphodiesterase 5 Inhibitors pharmacology, Prostatic Neoplasms mortality, Retrospective Studies, Survival Analysis, Phosphodiesterase 5 Inhibitors therapeutic use, Prostatectomy methods, Prostatic Neoplasms surgery
- Abstract
Purpose: To determine whether phosphodiesterase-5 inhibitor documentation is associated with biochemical relapse-free and overall survival of patients with prostate cancer treated with radical prostatectomy., Materials and Methods: We undertook a retrospective cohort analysis of 3,100 patients with prostate cancer treated with radical prostatectomy between 2003 and 2015. The patients were categorized as a phosphodiesterase- 5- inhibitor user or non-user. The biochemical relapse-free and overall survival at 5-years and 10-years were determined., Results: Of the patients, 1,372 reported phosphodiesterase-5 inhibitor documentation, and 1,728 did not. The biochemical recurrence-free survival for non-users at 5- and 10-years follow-up was 87.6% and 85.3%, respectively, and the overall survival at these time intervals was 97.9% and 94.5%. The biochemical recurrence-free survival for phosphodiesterase-5 inhibitor users was 94.3% and 93.2% at 5- and 10-years follow-up, respectively, and overall survival was 99.2% and 95.8% at these intervals. The hazard ratio for biochemical recurrence-free survival was 0.44 (CI 0.34-0.56) and for overall survival was 0.65 (CI 0.45-0.94). On the multivariate analysis, phosphodiesterase-5 inhibitor documentation was associated with a lower risk of biochemical recurrence and death when corrected for the other variables. Age at surgery and Gleason scores >8 was associated with a higher risk of death. Higher pathological stage, higher Gleason score, presence of lymph node metastases, and nonwhite race were associated with a higher risk of recurrence., Conclusion: This retrospective analysis revealed a significant association of postoperative phosphodiesterase-5 inhibitor documentation with biochemical recurrence-free- and overall survival in patients with localized prostate cancer treated with radical prostatectomy. Larger scale studies are warranted to investigate the clinical significance of this association., Competing Interests: Conflict of interest No authors have any conflicts of interest with subjects in this paper., (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
17. Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy.
- Author
-
Prabhu N, Kapur N, Catalona W, Leikin R, Helenowski I, Jovanovich B, Gurley M, Okwuosa TM, and Kuzel TM
- Subjects
- Aged, Cohort Studies, Disease-Free Survival, Humans, Male, Middle Aged, Neoplasm Recurrence, Local blood, Prostate-Specific Antigen blood, Prostatic Neoplasms blood, Survival Rate, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Neoplasm Recurrence, Local epidemiology, Prostatectomy methods, Prostatic Neoplasms epidemiology, Prostatic Neoplasms surgery, Risk Assessment
- Abstract
Background: Multiple studies have investigated the role of statins in prostate cancer (CaP), the leading cause of cancer related death in men. Retrospective cohort studies investigating the correlation between statin use and biochemical recurrence free (BCRF) survival in men with CaP have been inconclusive., Objectives: In the largest reported surgical cohort to date, we investigated the effect of statin therapy on BCRF and overall survival in patients with CaP who have undergone radical prostatectomy (RP)., Patients and Methods: We performed a retrospective analysis of men (n = 3,088) participating in the NCI funded Specialized Program of Research Excellence (SPORE) in CaP at Northwestern University (NM) in Chicago, Illinois. Patients were treated with RP between 2002 and 2015. Patients in the statin users group received treatment within 2 years prior to or subsequent to RP. Wilcoxon rank-sum and Fisher's exact tests were used to compare age, race, Gleason score, clinical staging, and pathological stage between statin users and nonstatin users., Results: The analysis identified 1,222 statin users and 1,865 nonusers (mean age 71 years, 92% Caucasian). After a median follow-up time of 49.0 months, the 5-year BCRF survival rate was 93.3% (95% confidence interval [CI]: 91.9-94.8%) among statin users and 88.6% (95% CI: 87.1%-90%) among nonusers (log-rank P< 0.001). After 10 years, the progression-free survival (PFS) was 91.7% (95% CI: 90.1%-93.3%) among statin users and 86.5% (95% CI: 84.4%-88.2%) among nonusers (log-rank P< 0.001)., Conclusions: Extended follow-up data in this large surgical cohort show statin use improves BCRF but not overall survival in RP patients., (Copyright © 2020. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
18. Standardized Observational Cancer Research Using the OMOP CDM Oncology Module.
- Author
-
Belenkaya R, Gurley M, Dymshyts D, Araujo S, Williams A, Chen R, and Reich C
- Subjects
- Databases, Factual, Registries, Electronic Health Records, Models, Theoretical, Neoplasms, Research
- Abstract
Observational research in cancer requires substantially more detail than most other therapeutic areas. Cancer conditions are defined through histology, affected anatomical structures, staging and grading, and biomarkers, and are treated with complex therapies. Here, we show a new cancer module as part of the OMOP CDM, allowing manual and automated abstraction and standardized analytics. We tested the model in EHR and registry data against a number of typical use cases.
- Published
- 2019
- Full Text
- View/download PDF
19. An Analysis of Extraocular Muscle Forces in the Piked Dogfish (Squalus acanthias).
- Author
-
Gurley M and Motta P
- Subjects
- Animals, Muscle Fibers, Skeletal physiology, Oculomotor Muscles anatomy & histology, Vision, Ocular physiology, Eye Movements physiology, Models, Biological, Muscle Contraction physiology, Oculomotor Muscles physiology, Squalus acanthias physiology
- Abstract
Vertebrates utilize six extraocular muscles that attach to a tough, protective sclera to rotate the eye. The goal of the study was to describe the maximum tetanic forces, as well as the torques produced by the six extraocular muscles of the piked dogfish Squalus acanthias to understand the forces exerted on the eye. The lateral rectus extraocular muscle of Squalus acanthias was determined to be parallel fibered with the muscle fibers bundled into discrete fascicles. The extraocular muscles attach to the sclera by muscular insertions. The total tensile forces generated by the extraocular muscles ranged from 1.18 N to 2.21 N. The torques of the extraocular muscles ranged from 0.39 N to 2.34 N. The torques were greatest in the principal direction of movement for each specific muscle. The lateral rectus produced the greatest total tensile force, as well as the greatest torque force component, while the medial rectus produced the second greatest. This is likely due to the constant rotational movement of the eye anteriorly and posteriorly to stabilize the visual image, as well as increase the effective visual field during swimming. Rotational forces in dimensions other than the primary direction of movement may contribute to motion in directions other than the principal direction during multi-muscle contraction that occurs in the vertebrate eye. Anat Rec, 2018. © 2018 Wiley Periodicals, Inc. Anat Rec, 302:837-844, 2019. © 2018 Wiley Periodicals, Inc., (© 2018 Wiley Periodicals, Inc.)
- Published
- 2019
- Full Text
- View/download PDF
20. Phantom evaluation of a cardiac SPECT/VCT system that uses a common set of solid-state detectors for both emission and transmission scans.
- Author
-
Bai C, Conwell R, Kindem J, Babla H, Gurley M, De Los Santos R 2nd, Old R, Weatherhead R, Arram S, and Maddahi J
- Subjects
- Humans, Image Processing, Computer-Assisted, Myocardial Perfusion Imaging, Tomography, Emission-Computed, Single-Photon methods, Heart diagnostic imaging, Tomography, Emission-Computed, Single-Photon instrumentation
- Abstract
Background: We developed a cardiac SPECT system (X-ACT) with low dose volume CT transmission-based attenuation correction (AC). Three solid-state detectors are configured to form a triple-head system for emission scans and reconfigured to form a 69-cm field-of-view detector arc for transmission scans. A near mono-energetic transmission line source is produced from the collimated fluorescence x-ray emitted from a lead target when the target is illuminated by a narrow polychromatic x-ray beam from an x-ray tube. Transmission scans can be completed in 1 min with insignificant patient dose (deep dose equivalent <5 muSv)., Methods: We used phantom studies to evaluate (1) the accuracy of the reconstructed attenuation maps, (2) the effect of AC on image uniformity, and (3) the effect of AC on defect contrast (DC). The phantoms we used included an ACR phantom, an anthropomorphic phantom with a uniform cardiac insert, and an anthropomorphic phantom with two defects in the cardiac insert., Results: The reconstructed attenuation coefficient of water at 140 keV was .150 +/- .003/cm in the uniform region of the ACR phantom, .151 +/- .003/cm and .151 +/- .002/cm in the liver and cardiac regions of the anthropomorphic phantom. The ACR phantom images with AC showed correction of the bowing effect due to attenuation in the images without AC (NC). The 17-segment scores of the images of the uniform cardiac insert were 78.3 +/- 6.5 before and 87.9 +/- 3.3 after AC (average +/- standard deviation). The inferior-to-anterior wall ratio and the septal-to-lateral wall ratio were .99 and 1.16 before and 1.02 and 1.00 after AC. The DC of the two defects was .528 and .156 before and .628 and .173 after AC., Conclusion: The X-ACT system generated accurate attenuation maps with 1-minute transmission scans. AC improved image quality and uniformity over NC.
- Published
- 2010
- Full Text
- View/download PDF
21. Development and evaluation of a new fully automatic motion detection and correction technique in cardiac SPECT imaging.
- Author
-
Bai C, Maddahi J, Kindem J, Conwell R, Gurley M, and Old R
- Subjects
- Artifacts, Automation, Cardiology instrumentation, Cardiology methods, Equipment Design, Humans, Image Interpretation, Computer-Assisted methods, Image Processing, Computer-Assisted, Observer Variation, Perfusion Imaging methods, Phantoms, Imaging, Reproducibility of Results, Software, Heart diagnostic imaging, Myocardium pathology, Tomography, Emission-Computed, Single-Photon instrumentation, Tomography, Emission-Computed, Single-Photon methods
- Abstract
Background: In cardiac SPECT perfusion imaging, motion correction of the data is critical to the minimization of motion introduced artifacts in the reconstructed images. Software-based (data-driven) motion correction techniques are the most convenient and economical approaches to fulfill this purpose. However, the accuracy is significantly affected by how the data complexities, such as activity overlap, non-uniform tissue attenuation, and noise are handled., Methods: We developed STASYS, a new, fully automatic technique, for motion detection and correction in cardiac SPECT. We evaluated the performance of STASYS by comparing its effectiveness of motion correcting patient studies with the current industry standard software (Cedars-Sinai MoCo) through blind readings by two readers independently., Results: For 204 patient studies from multiple clinical sites, the first reader identified (1) 69 studies with medium to large axial motion, of which STASYS perfectly or significantly corrected 86.9% and MoCo 72.5%; and (2) 20 studies with medium to large lateral motion, of which STASYS perfectly or significantly corrected 80.0% and MoCo 60.0%. The second reader identified (1) 84 studies with medium to large axial motion, of which STASYS perfectly or significantly corrected 82.2% and MoCo 76.2%; and (2) 34 studies with medium to large lateral motion, of which STASYS perfectly or significantly corrected 58.9% and MoCo 50.0%., Conclusions: We developed a fully automatic software-based motion correction technique, STASYS, for cardiac SPECT. Clinical studies showed that STASYS was effective and corrected a larger percent of cardiac SPECT studies than the current industrial standard software.
- Published
- 2009
- Full Text
- View/download PDF
22. Sigmoid sinus thrombosis associated with internal jugular venous occlusion: direct thrombolytic treatment.
- Author
-
Gurley MB, King TS, and Tsai FY
- Subjects
- Adult, Female, Humans, Middle Aged, Radiography, Sinus Thrombosis, Intracranial complications, Sinus Thrombosis, Intracranial diagnostic imaging, Thrombosis complications, Thrombosis diagnostic imaging, Angioplasty, Balloon, Cranial Sinuses, Jugular Veins, Plasminogen Activators therapeutic use, Sinus Thrombosis, Intracranial therapy, Thrombolytic Therapy methods, Thrombosis therapy, Urokinase-Type Plasminogen Activator therapeutic use
- Abstract
Purpose: To report our experience with transfemoral direct venous thrombolysis and angioplasty to treat central venous and dural sinus occlusion. The cases presented are rare examples of internal jugular occlusion associated with sigmoid sinus thrombosis., Methods and Results: Two middle-aged, symptomatic female patients were diagnosed with sigmoid sinus and internal jugular vein thrombosis. Venography was performed from a contralateral transfemoral approach, followed immediately by urokinase infusion directly to the occlusion using an intermittent "burst-bolus" technique. Successful thrombolysis of the sigmoid sinus and internal jugular vein was documented in both patients. In one case, a venous stenosis was treated with balloon angioplasty. Clinical signs and symptoms resolved in both patients., Conclusions: Occluded dural sinuses and central veins can be treated with direct administration of thrombolytic agents. When an underlying stenosis is identified, balloon dilation should be used to reduce the likelihood of recurrence.
- Published
- 1996
- Full Text
- View/download PDF
23. Determining ICU visiting hours.
- Author
-
Gurley MJ
- Subjects
- Attitude of Health Personnel, Family psychology, Humans, Nursing Staff, Hospital psychology, Patient Care Planning, Intensive Care Units, Visitors to Patients
- Abstract
Visiting hours play an integral role in the intensive care unit (ICU) for both patients and health care providers. Family members offer support and comfort to patients during critical illnesses. Nurses, however, often view visiting hours as intrusive and time consuming. The issue of restricted versus open visiting hours continues in many ICUs, and the advantages and disadvantages of both types of visitation must be weighed before selecting the visiting hours appropriate for the institution.
- Published
- 1995
24. Appetite for alcohol: influence of genetics and early experience.
- Author
-
Jones B, Goldstine R, Gurley M, and Reyes E
- Subjects
- Animals, Appetite, Ethanol, Genotype, Mice, Mice, Inbred BALB C, Mice, Inbred C3H, Mice, Inbred C57BL, Species Specificity, Alcohol Drinking, Handling, Psychological
- Abstract
Thirty male mice from three inbred strains (C57BL/10J, BALB/cJ, C3H/2Ibg) were assigned to infantile handling or control conditions. At sixty days of age, all animals were tested in a two-choice situation for selection of 10% ethanol vs. water. Consumption from both drinking tubes was recorded for 15 days and selection ratios for alcohol per total fluid volume were calculated. C57 mice demonstrated increased preference for alcohol as a result of early handling. The BALB strain, known for low preference for alcohol, showed increased preference for alcohol as well. C3H mice evinced a biphasic effect of early handling, showing an initially greater acceptance of alcohol as compared to controls, followed by decreased selection.
- Published
- 1985
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.